Europe’s IT, Business Services Market Boosted by AI-Driven Cloud Demand in Q2: ISG Index™
Combined market up 14% in Q2, driven by 34% growth in XaaSManaged services off 4%, as companies limit discretionary spending
Strong interest in AI continued to drive cloud services growth in Europe during the second quarter, even as demand for managed services slowed under the weight of macro uncertainty, according to the latest state-of-the-industry report from Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm.
The EMEA ISG Index™, which measures commercial outsourcing contracts with annual contract value (ACV) of US $5 million or more, shows second-quarter ACV for the combined market (both managed services and cloud-based as-a-service) advanced 14 percent, to US $9.0 billion. Although up double digits year on year, the combined market declined 1.2 percent sequentially from the first quarter, as economic and geopolitical concerns limited discretionary spending on managed services.
“Europe continues to embrace the cloud for AI adoption and cost efficiency,” said Steve Hall, president, ISG EMEA and the firm’s chief AI officer. “Given the region’s macroeconomic and geopolitical instability, there has been a lot of discussion around digital sovereignty in Europe. We view sovereign clouds as a potential growth segment for the industry going forward.”
Second-Quarter Results by Segment
ACV for the as-a-service (XaaS) segment soared 34 percent year on year, to a record US $5.1 billion, and was up 7 percent sequentially from the first quarter. It was the fifth straight quarter XaaS has grown by double digits, averaging 31 percent in that span, although the Q2 growth rate moderated slightly (down 170 basis points) from Q1.
Within this segment, infrastructure-as-a-service (IaaS) climbed 43 percent year on year, to a record US $3.9 billion, while growing 13 percent from the first quarter. Software-as-a-service (SaaS) grew 12 percent versus the prior year, to US $1.2 billion, although it was down 7 percent sequentially.
Managed services ACV in the second quarter dipped 4 percent, to US $3.9 billion, and was down 11 percent sequentially from the first quarter. A total of 240 managed services contracts were awarded in the quarter, down 20 percent from the prior year and down 14 percent from Q1. Among them were three mega deals (ACV of US $100 million or more), compared with four signed in the second quarter last year. Still, the total ACV of the mega deals was up 9 percent year on year, as companies continued to emphasize larger deals aimed cost optimization. The volume of smaller deals under US $10 million declined 31 percent year on year, as enterprises limited discretionary projects.
Within managed services, IT outsourcing (ITO) slumped 21 percent, to US $2.6 billion, with data center services the only growth area. Business process outsourcing (BPO), meanwhile, rose 23 percent, to US $667 million, led by growth in customer engagement, facilities management and finance and accounting services.
By industry, managed services ACV was higher in travel, transportation and leisure (up 90 percent), business services (up 74 percent) and retail (up 10 percent), while the region’s three largest sectors showed mixed results. Energy and manufacturing were up 4 percent and 3 percent, respectively, but banking, financial services and insurance (BFSI), Europe’s largest industry for sourcing, fell 8 percent.
ACV in the engineering, research and development (ER&D) segment, meanwhile, reached US $953 million, up 193 percent year on year and up 64 percent from the first quarter, as companies invested in digital integration and innovation.
Geographic Performance
EMEA's largest managed services market, the DACH region, grew 11 percent year on year, to US $1.0 billion, while France rose to the number two spot for ACV, at US $817 million, up 142 percent from the prior year. The UK, traditionally Europe’s largest sourcing market, dropped to third place, at US $770 million, down 41 percent from the prior year. The Nordics, coming in fourth, climbed 72 percent, to US $471 million of ACV.
First-Half Results
For the first half, combined market ACV rose 19 percent, to US $18.2 billion. Managed services, at US $8.3 billion, was up 3.4 percent, while XaaS, at US $9.9 billion, rose 35 percent versus the same period last year. A total of 518 managed services contracts were awarded in the half, down 11 percent from last year, including six mega-deals, even with the prior year. The total ACV of the mega-deals, however, advanced 10 percent year on year.
Within managed services, ITO was essentially flat (up 0.2 percent), at US $6.1 billion, while BPO declined 16 percent, to US $1.2 billion. On the cloud side, the IaaS market grew 41 percent, to US $7.4 billion, while the SaaS market rose 20 percent, to US $2.5 billion.
ER&D services more than doubled from the prior year, to $953 million of ACV.
2025 Global Forecast
For the full year, ISG is maintaining its forecast of 1.3 percent revenue growth for managed services, reflecting a stabilizing tariff environment but also continued weakness in discretionary spending. At the same time, ISG is raising its previous growth forecast for cloud-based XaaS by 300 basis points, to 21 percent, based on continuing strong demand for AI-driven transformation.
Hall commented: “In terms of our macro outlook, it has improved over the last 90 days, yet business uncertainty remains high. That said, AI has emerged as the dominant theme, overcoming many of these concerns to drive the overall market forward.”
About the ISG Index™
The ISG Index™ is recognized as the authoritative source for marketplace intelligence on the global technology and business services industry. For 91 consecutive quarters, it has detailed the latest industry data and trends for financial analysts, enterprise buyers, software and service providers, law firms, universities and the media.
The 2Q25 Global ISG Index results were presented during a webcast on July 10. To view a replay of the webcast and download presentation slides, visit this webpage.
About ISG
ISG (Nasdaq: III) is a global AI-centered technology research and advisory firm. A trusted partner to more than 900 clients, including 75 of the world’s top 100 enterprises, ISG is a long-time leader in technology and business services that is now at the forefront of leveraging AI to help organizations achieve operational excellence and faster growth. The firm, founded in 2006, is known for its proprietary market data, in-depth knowledge of provider ecosystems, and the expertise of its 1,600 professionals worldwide working together to help clients maximize the value of their technology investments.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250714957081/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CSC Research Finds 40% of Enterprises Could Be at Risk of an Outage Due to SSL Expiration14.7.2025 15:00:00 CEST | Press release
Domain control validation sunsets on July 15, 2025, putting many companies that rely on WHOIS email at risk for service disruption New research fromCSC, an enterprise-class domain security provider and world leader in domain management, SSL management, brand protection, and anti-fraud solutions, indicates that as many as 40% of enterprises are at risk of unexpected service outages caused by out-of-date secure sockets layer (SSL) certificates. This threat stems from the reliance on WHOIS-based email addresses for domain control validation (DCV) that will be officially deprecated on July 15, 2025. CSC analyzed over 100,000 global SSL certificate records and found that many organizations still use WHOIS email as their primary method for domain control validation, despite a 2024 vote by the CA/Browser Forum that mandates the deprecation of WHOIS-based validation due to its associated security vulnerabilities. After July 15, 2025, certificate authorities (CAs) will no longer accept WHOIS em
SBC Medical Appoints Dr. Steven R. Cohen as Medical Strategy Advisor to Accelerate Global Expansion14.7.2025 15:00:00 CEST | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced the appointment of Dr. Steven R. Cohen, a globally recognized leader in plastic and craniofacial surgery, as Medical Strategy Advisor. His appointment marks a significant step in the company’s strategy to expand its global footprint and enhance its medical excellence. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250714547888/en/ Dr. Cohen Dr. Cohen is the Founder of Faces+, an advanced aesthetic and reconstructive surgery center in San Diego, California. With over 30 years of clinical experience, he is widely known for his pioneering work in regenerative aesthetics, including the clinical application of fat-derived stem cells, skeletal facial aesthetic surgery, and the integration of artificial intelligence into medical in
PCI Pharma Services Enters Next Phase of Growth With Strategic Investment from Bain Capital, Kohlberg, and Mubadala14.7.2025 14:30:00 CEST | Press release
Investment Will Accelerate PCI’s Leading Position in CDMO, Delivering Life-Changing Therapies to PatientsTransaction Includes Continued Investment from Partners Group PCI Pharma Services (“PCI” or the “Company”), a world-leading global contract development and manufacturing organization (CDMO) focused on innovative biotherapies, today announced that it received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, and supported with significant reinvestment by Mubadala Investment Company (“Mubadala”). Partners Group will also continue to support the Company with a minority investment. Financial terms of the private transaction were not disclosed. Headquartered in Philadelphia, Pennsylvania, PCI provides clients with integrated end-to-end drug development, manufacturing and packaging capabilities that increase their products’ speed to market and opportunities for commercial success. PCI brings the proven experience that comes with more than 450 successful pr
Stone Point Capital Closes Tenth Flagship Fund with $11.5 Billion of Committed Capital14.7.2025 14:30:00 CEST | Press release
Fund Surpassed Hard Cap and Is the Largest Fundraise in the Firm’s History Stone Point Capital LLC, a private equity firm focused on financial services and related industries, today announced the final closing of its tenth private equity fund, Trident X, with $11.5 billion in total commitments. Trident X exceeded its original target and hard cap of $9 billion and is approximately $2.5 billion larger than Trident IX, a $9 billion fund, which closed in 2022. Trident X received strong support from its existing investor base, as well as first-time commitments from a number of leading institutional investors globally. General Partner and affiliated entities contributed approximately $750 million. “We are grateful to our limited partners for their continued trust and support, and we are proud of the enduring strength of our Trident Funds over 30 years and many market cycles,” said Chuck Davis, Chairman and Co-Chief Executive Officer of Stone Point Capital. “With Trident X, we will continue d
Vertex Named a Premier, Inc. Breakthroughs Innovation Celebration Winner for JOURNAVX™, a First-in-Class Non-Opioid Treatment for Adults With Moderate-to-Severe Acute Pain14.7.2025 14:30:00 CEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it has been named a 2025 Breakthroughs Innovation Celebration winner by Premier, Inc., a leading health care improvement company. The honor recognizes JOURNAVX™ (suzetrigine), an oral, non-opioid, highly selective NaV1.8 pain signal inhibitor for the treatment of adults with moderate-to-severe acute pain, as a groundbreaking health care technology. “We are honored to be recognized at Premier’s 2025 Innovation Celebration. This reflects our unwavering commitment to bringing innovative medicines, like JOURNAVX — a non-opioid and the first new class of pain medicine approved in decades — to patients with significant unmet need,” said Duncan McKechnie, Executive Vice President and Chief Commercial Officer at Vertex. “Premier proudly acknowledges Vertex’s outstanding commitment to advancing health care,” said Bruce Radcliff, Senior Vice President, Supply Chain, at Premier. “Their innovative product, recognized at our 20
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom